Diabetic Neuropathy



Light-emitting-diode in Diabetic Subjects


Condition:   Diabetic Neuropathies
Interventions:   Device: Red Light-emitting diode device;   Device: Infrared Light-emitting diode device
Sponsor:   Rinaldo Roberto de Jesus Guirro
Not yet recruiting


Peripheral Analgesia in Painful Diabetic Neuropathy


Conditions:   Diabetic Neuropathy Peripheral;   Neuropathic Pain;   Diabetic Foot Infection
Interventions:   Procedure: Continuous peripheral nerve blocks;   Procedure: Analgesic treatment
Sponsor:   Centre Hospitalier Universitaire de la Réunion
Not yet recruiting


An Evaluation of an SCCD on the Symptomatology of Painful DPN


Condition:   Painful Diabetic Neuropathy
Intervention:   Device: Flowaid FA-100 SCCD
Sponsor:   Rosenblum, Jonathan I., DPM
Recruiting


Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)


Condition:   Painful Diabetic Neuropathy
Interventions:   Drug: EMA401;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting


Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain


Condition:   Painful Diabetic Neuropathy
Interventions:   Device: Senza HF10 Therapy;   Other: CMM
Sponsor:   Nevro Corp
Recruiting


Trazodone in Painful Diabetic Neuropathy


Condition:   Painful Diabetic Neuropathy
Interventions:   Drug: Trazodone 20 mg;   Drug: Trazodone 10 mg;   Drug: Placebo
Sponsors:   Aziende Chimiche Riunite Angelini Francesco S.p.A;   Chiltern International Inc.
Recruiting


0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy


Condition:   Peripheral Diabetic Neuropathy
Interventions:   Drug: 0.075% Capsaicin Lotion;   Drug: placebo
Sponsor:   Thammasat University
Recruiting


Graded Exposure in Patients With Painful Diabetic Neuropathy


Conditions:   Painful Diabetic Neuropathy;   Diabetic Neuropathies, Painful;   Neuralgia, Diabetic
Intervention:   Behavioral: Graded Exposure
Sponsor:   Maastricht University Medical Center
Recruiting


Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy


Condition:   Diabetic; Neuropathic, Polyneuropathy (Manifestation)
Interventions:   Drug: 3% oxybutynin;   Drug: Placebo
Sponsors:   Eastern Virginia Medical School;   Impeto Medical
Recruiting


Corneal Confocal Microscopy in Patients With Type 1 Diabetes


Condition:   Diabetic Neuropathies
Interventions:   Device: Corneal confocal microscopy;   Procedure: Skin biopsy;   Procedure: Nerve conduction study;   Other: Blood draw
Sponsor:   Albert Einstein College of Medicine, Inc.
Not yet recruiting


A Study to Evaluate PEMF Therapy on Experimentally Inducted Pain in Subjects With Painful Peripheral Diabetic Neuropathy


Condition:   Painful Peripheral Diabetic Neuropathy
Intervention:   Device: Provant
Sponsor:   Regenesis Biomedical, Inc.
Completed


Efficacy of Near Infrared Phototherapy in Type 2 Diabetic Neuropathy


Condition:   Neuropathy
Interventions:   Other: Infrared Phototherapy;   Other: Sham
Sponsors:   Healthlight, LLC;   Clin-Assist, LLC;   Midwest Medical Research
Terminated


Effects of Foot Muscle Strengthening in Daily Activity in Diabetic Neuropathic Patients


Condition:   Diabetic Neuropathies
Intervention:   Other: Intervention Group
Sponsor:   University of Sao Paulo General Hospital
Recruiting


Nociceptive Pain Fiber Response


Condition:   Painful Peripheral Diabetic Neuropathy
Intervention:   Device: Provant Therapy System
Sponsor:   Regenesis Biomedical, Inc.
Completed


The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy


Conditions:   Painful Diabetic Neuropathy;   Diabetic Neuropathy;   Neuropathy
Interventions:   Drug: Clonidine Hydrochloride Topical Gel, 0.1%;   Drug: Clonidine Hydrochloride Gel Comparator
Sponsor:   BioDelivery Sciences International
Completed


Phase 3 Gene Therapy for Painful Diabetic Neuropathy


Conditions:   Painful Diabetic Neuropathy;   Diabetic Neuropathy, Painful
Interventions:   Genetic: VM202;   Genetic: placebo
Sponsors:   ViroMed Co., Ltd. dba VM BioPharma;   MedTech Consultants Inc.
Recruiting


Understanding Risk Factors and Determinants for Neuropathic Pain


Condition:   Diabetic Neuropathy
Intervention:  
Sponsors:   Rambam Health Care Campus;   European Union
Recruiting


A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy


Conditions:   Painful Diabetic Neuropathy;   Diabetes
Intervention:   Drug: clonidine hydrochloride topical gel, 0.1%
Sponsor:   BioDelivery Sciences International
Completed


Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy


Conditions:   Painful Diabetic Neuropathy;   Diabetic Neuropathy;   Neuropathy
Interventions:   Drug: Clonidine Gel 0.1%;   Drug: Placebo
Sponsor:   BioDelivery Sciences International
Completed


Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)


Condition:   Diabetic Neuropathy, Painful
Interventions:   Drug: MK-6096;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?


Condition:   Diabetic Neuropathy
Intervention:   Procedure: Nerve conduction study and Ultrasound of the PTN
Sponsor:   University Health Network, Toronto
Completed


The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy


Conditions:   Diabetic Neuropathies;   Complex Regional Pain Syndrome Type II;   Resistant Peripheral Neuropathic Pain;   Chemotherapy Induced Pain Neuropathy
Intervention:   Device: TDCS/sham procedure on five consecutive days
Sponsor:   Soroka University Medical Center
Withdrawn


Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.


Condition:   Painful Diabetic Neuropathy
Intervention:   Drug: Lacosamide
Sponsor:   UCB Pharma
Completed


Dose-effect of SSR180575 in Diabetic Neuropathy


Condition:   Diabetic Neuropathies
Interventions:   Drug: SSR180575;   Drug: Placebo
Sponsor:   Sanofi
Completed


A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy


Condition:   Diabetic Neuropathy
Intervention:   Drug: lacosamide
Sponsor:   UCB Pharma
Completed

Refine Your Search Advanced Search